Vimarsana
Biggest News Aggregation in the World

Page 8 - Consortium For News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Consortium For. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Consortium For Today - Breaking & Trending Today

Financial News Media | Data Governance Market Value Could Exceed $5 Billion By 2025 - Vimarsana News

Financial News Media | Data Governance Market Value Could Exceed $5 Billion By 2025

Palm Beach, FL – January 21, 2021 – In spite of the recent global pandemic, the global data governance market has been growing and is expected to continue for years to come. Data governance is a set of processes that ensures the systematic management and protection of important and critical data throughout the organization. It ensures trusted information is used for accounting, decision-making, and other critical business processes. With the advent of several data regulations by governments, it has become more critical than ever to ensure data within an organization is stored, used, and d...

ABIONYX Pharma: ABIONYX Initiates a Phase 2a Clinical Trial With CER-001 in Septic Patients at High Risk of Developing Acute Kidney Injury - Vimarsana News

ABIONYX Pharma: ABIONYX Initiates a Phase 2a Clinical Trial With CER-001 in Septic Patients at High Risk of Developing Acute Kidney Injury

ABIONYX Pharma: ABIONYX Initiates a Phase 2a Clinical Trial With CER-001 in Septic Patients at High Risk of Developing Acute Kidney Injury Temporary Authorization for Named Use (ATUn) showed promising efficacy in renal diseases Evaluation of the clinical activity by dosage level of CER-001 in the prevention of Acute Kidney Injury in ICU patients with septicemia A potentially modifying effect on the progression of the inflammatory cascade in sepsis Pending positive data, the company aims to move into Phase 2b by end of 2021 Regulatory News: ABIONYX Pharma ( FR0012616852 ABNX PEA PME eligible),...